AbbVie Inc. against Novartis AG — live side-by-side technical comparison.
Prices as of 2026-11-10T21:02:16+00:00 UTC · updates daily
ABBV leads 5 of the 6 windows we measure — over 1 month ABBV is +6.3% and NVS +13.6%; over year to date ABBV is +28.6% and NVS +18.4%. The ABBV/NVS price ratio stands at 1.8001, below its 50-day average of 1.8353, and above the 200-day average of 1.5749. A ratio above its own average means ABBV is gaining on NVS; on this reading the recent edge belongs to NVS.
Compare ABBV and NVS: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| ABBV | NVS | |
|---|---|---|
| Price | $293.89 | $163.26 |
| 1 day | +0.2%lead | -0.3% |
| 5 days | +2.8%lead | +2.5% |
| 1 month | +6.3% | +13.6%lead |
| 6 months | +45.8%lead | +11.8% |
| Year to date | +28.6%lead | +18.4% |
| 1 year | +34.4%lead | +28.3% |
| 2 years | +47.3% | — |
| 52-week position | 92% of range | 85% of range |
| 52-week range | $190.75–$302.93 | $123.24–$170.46 |
| vs 50-day average | above $273.45 | above $149.25 |
| vs 200-day average | above $239.68 | above $152.41 |
| RSI (14) | 62 | 65 |
| Market cap | $519.5B | — |
| Analyst target | $310.65 (+5.7%) | — |
| Analysts | 26 | — |
| Consensus | Buy | — |
| Next earnings | Oct 30, 2026 | Oct 27, 2026 |
ABBV trades at $293.89, above its 50-day average of $273.45, and above the 200-day at $239.68. It sits at 92% of its 52-week range ($190.75–$302.93); 14-day RSI is 62, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $294.89 (0.3% away) and the first support below is $275.00 (6.4% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
NVS trades at $163.26, above its 50-day average of $149.25, and above the 200-day at $152.41. It sits at 85% of its 52-week range ($123.24–$170.46); 14-day RSI is 65, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $168.62 (3.3% away) and the first support below is $160.57 (1.6% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
ABBV is the more volatile of the two — an average session moves it 2.5% against 2.3% for NVS, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: ABBV clearing $294.89 or losing $275.00; NVS clearing $168.62 or losing $160.57. Until one of them gives way, the relative reading above stands.